Cargando…
An Outbreak of Parvovirus B19 in Israel
Human parvovirus B19 (B19V) has a wide clinical spectrum, ranging from an asymptomatic infection to a life threatening one. During pregnancy, it can lead to fetal loss and hydrops fetalis. This retrospective study examined the incidence rates of B19V in Israel, analyzing anonymized electronic medica...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674631/ https://www.ncbi.nlm.nih.gov/pubmed/38005937 http://dx.doi.org/10.3390/v15112261 |
_version_ | 1785149731754737664 |
---|---|
author | Patalon, Tal Saciuk, Yaki Trotzky, Daniel Pachys, Gal Ben-Tov, Amir Segal, Yaakov Gazit, Sivan |
author_facet | Patalon, Tal Saciuk, Yaki Trotzky, Daniel Pachys, Gal Ben-Tov, Amir Segal, Yaakov Gazit, Sivan |
author_sort | Patalon, Tal |
collection | PubMed |
description | Human parvovirus B19 (B19V) has a wide clinical spectrum, ranging from an asymptomatic infection to a life threatening one. During pregnancy, it can lead to fetal loss and hydrops fetalis. This retrospective study examined the incidence rates of B19V in Israel, analyzing anonymized electronic medical records of 2.7 million individuals between January 2015 and September 2023. A generalized linear model with a Poisson distribution was fit to the data, adjusting for potential confounders. A marked increase in B19V was observed in 2023, with an adjusted incidence rate ratio (IRR) of 6.6 (95% CI 6.33–6.89) when comparing 2023 to previous years. When specifically comparing 2023 to COVID-19 years (2020–2022), adjusted IRR climbs to 9.21 (8.66–9.80). Moreover, in 2023, previously existing seasonality has largely disappeared. High SES characterized most infected individuals with a marked discrepancy in social sectors; the Arab population was significantly less likely to be found B19V positive, even when adjusting for SES. Most infections occurred in school-aged children (6–11 years old). Pregnant women experienced the most significant rise in B19V, with an adjusted IRR of 11.47 (9.44–13.97) in 2023 compared to previous years; most cases were diagnosed in the first trimester. This study demonstrates that Israel is currently experiencing the largest and longest reported outbreak of B19V to date. Policymakers should consider setting screening policies in place, at least for populations at risk, while specifically studying and potentially targeting low socioeconomic populations and specific social sectors to avoid health inequalities. |
format | Online Article Text |
id | pubmed-10674631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106746312023-11-16 An Outbreak of Parvovirus B19 in Israel Patalon, Tal Saciuk, Yaki Trotzky, Daniel Pachys, Gal Ben-Tov, Amir Segal, Yaakov Gazit, Sivan Viruses Article Human parvovirus B19 (B19V) has a wide clinical spectrum, ranging from an asymptomatic infection to a life threatening one. During pregnancy, it can lead to fetal loss and hydrops fetalis. This retrospective study examined the incidence rates of B19V in Israel, analyzing anonymized electronic medical records of 2.7 million individuals between January 2015 and September 2023. A generalized linear model with a Poisson distribution was fit to the data, adjusting for potential confounders. A marked increase in B19V was observed in 2023, with an adjusted incidence rate ratio (IRR) of 6.6 (95% CI 6.33–6.89) when comparing 2023 to previous years. When specifically comparing 2023 to COVID-19 years (2020–2022), adjusted IRR climbs to 9.21 (8.66–9.80). Moreover, in 2023, previously existing seasonality has largely disappeared. High SES characterized most infected individuals with a marked discrepancy in social sectors; the Arab population was significantly less likely to be found B19V positive, even when adjusting for SES. Most infections occurred in school-aged children (6–11 years old). Pregnant women experienced the most significant rise in B19V, with an adjusted IRR of 11.47 (9.44–13.97) in 2023 compared to previous years; most cases were diagnosed in the first trimester. This study demonstrates that Israel is currently experiencing the largest and longest reported outbreak of B19V to date. Policymakers should consider setting screening policies in place, at least for populations at risk, while specifically studying and potentially targeting low socioeconomic populations and specific social sectors to avoid health inequalities. MDPI 2023-11-16 /pmc/articles/PMC10674631/ /pubmed/38005937 http://dx.doi.org/10.3390/v15112261 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Patalon, Tal Saciuk, Yaki Trotzky, Daniel Pachys, Gal Ben-Tov, Amir Segal, Yaakov Gazit, Sivan An Outbreak of Parvovirus B19 in Israel |
title | An Outbreak of Parvovirus B19 in Israel |
title_full | An Outbreak of Parvovirus B19 in Israel |
title_fullStr | An Outbreak of Parvovirus B19 in Israel |
title_full_unstemmed | An Outbreak of Parvovirus B19 in Israel |
title_short | An Outbreak of Parvovirus B19 in Israel |
title_sort | outbreak of parvovirus b19 in israel |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674631/ https://www.ncbi.nlm.nih.gov/pubmed/38005937 http://dx.doi.org/10.3390/v15112261 |
work_keys_str_mv | AT patalontal anoutbreakofparvovirusb19inisrael AT saciukyaki anoutbreakofparvovirusb19inisrael AT trotzkydaniel anoutbreakofparvovirusb19inisrael AT pachysgal anoutbreakofparvovirusb19inisrael AT bentovamir anoutbreakofparvovirusb19inisrael AT segalyaakov anoutbreakofparvovirusb19inisrael AT gazitsivan anoutbreakofparvovirusb19inisrael AT patalontal outbreakofparvovirusb19inisrael AT saciukyaki outbreakofparvovirusb19inisrael AT trotzkydaniel outbreakofparvovirusb19inisrael AT pachysgal outbreakofparvovirusb19inisrael AT bentovamir outbreakofparvovirusb19inisrael AT segalyaakov outbreakofparvovirusb19inisrael AT gazitsivan outbreakofparvovirusb19inisrael |